ezgif.com-gif-maker-11

Daxxify®

The Only Long-Lasting, Peptide Powered Treatment

Daxxify® may last up to twice as long as conventional frown line treatments for some.*

*Conventional frown line treatments last 3-4 months. At least 50% of patients in clinical studies had no or minor frown lines 6 months after treatment with Daxxify®. In other safety studies, between 5% and 17% of patients still had noticeable improvement 9 months after treatment. 

FAQs

DAXXIFY® is FDA-approved to smooth moderate to severe lines between the brows. It is the only long-lasting frown line treatment powered by a peptide with results that last on average 6 months and up to 9 months for some.*

The active ingredient in DAXXIFY® is a purified protein called botulinum toxin type A.

*At least 50% of patients in clinical studies had no or minor frown lines 6 months after treatment. Between 3% and 5% of patients in clinical studies had no or minor frown lines 9 months after treatment. In other safety studies, between 5% and 17% of patients still had noticeable improvement 9 months later.

Is your frown line treatment not lasting as long as you would like? If so, DAXXIFY® could be the solution for you. Discuss your treatment goals with your aesthetic services provider.

All frown line treatments require a special ingredient to stabilize botulinum toxin A, the protein responsible for helping smooth moderate to severe frown lines. For instance, BOTOX® Cosmetic uses human serum albumin (HSA), a blood product, as its stabilizer. Dysport®, another frown line treatment, uses HSA as a stabilizer and cow’s milk protein as a protectant.

DAXXIFY® is unique because it is the only formulation that uses a novel peptide as a stabilizer and does not contain human or animal byproducts.

DAXXIFY® is the only long-lasting frown line treatment powered by a peptide.

Results last on average 6 months and up to 9 months for some.

All frown line treatments require a special ingredient to stabilize botulinum toxin A, the protein responsible for helping smooth moderate to severe frown lines. For instance, BOTOX® Cosmetic uses human serum albumin (HSA), a blood product, as its stabilizer. Dysport®, another frown line treatment, uses HSA as a stabilizer and cow’s milk protein as a protectant.

DAXXIFY® is unique because it is the only formulation that uses a novel peptide as a stabilizer and does not contain human or animal byproducts.

†At least 50% of patients in clinical studies had no or minor frown lines 6 months after treatment. Between 3% and 5% of patients in clinical studies had no or minor frown lines 9 months after treatment. In other safety studies, between 5% and 17% of patients still had noticeable improvement 9 months later.

In short, no, and here’s why. Units are like fingerprints—they are a proprietary measurement of a treatment’s unique potency.

Because of the differences in how treatments are formulated and tested, you cannot compare or convert Units between them, just like you cannot compare 2 fingerprints.

A clearer way to understand dosing is to look at how many nanograms of active ingredient (botulinum toxin type A) a product has.

Double the Units does not mean double the dose.

DAXXIFY®

Approved frown line dose: 40 Units

Amount of active ingredient: 0.18 nanograms

BOTOX® Cosmetic

Approved frown line dose: 20 Units

Amount of active ingredient: 0.18 nanograms

As you can see, despite the number of Units, DAXXIFY® isn’t 2x the dose of BOTOX® Cosmetic. Talk to your provider about DAXXIFY® and your aesthetic goals.

DAXXIFY® is manufactured in California, and the only prescription frown line treatment made in the United States. Conventional frown line treatments are manufactured in other countries, then imported into the United States.

allenmedicalaestheticslogo

SCHEDULE YOUR CONSULTATION

Contact Us Today

Please contact us if you have any questions!

Book Appointment